Celldex Therapeutics to Present at 3rd Annual Evercore ISI HealthCONx Conference

Rhea-AI Summary

Celldex Therapeutics (NASDAQ:CLDX) will participate in a fireside chat at the 3rd Annual Evercore ISI HealthCONx Conference on December 2 at 4:20 PM ET. A webcast of the presentation will be available on their website, with a replay accessible for 14 days post-event. Celldex focuses on developing monoclonal and bispecific antibodies aimed at treating critical diseases, including inflammatory conditions and various cancers. For detailed information about Celldex's work, visit: www.celldex.com.

HAMPTON, N.J., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that the Company will participate in a fireside chat at the 3rd Annual Evercore ISI HealthCONx Conference on Wednesday, December 2 at 4:20 pm ET.

A webcast of the presentation will be available on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay will be available for fourteen days following the event.

About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Visit www.celldex.com.

Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
Celldex Therapeutics, Inc.
(781) 433-3161
scavanaugh@celldex.com

FAQ

When will Celldex Therapeutics participate in the Evercore ISI HealthCONx Conference?

Celldex Therapeutics will participate in the Evercore ISI HealthCONx Conference on December 2 at 4:20 PM ET.

How can I watch Celldex Therapeutics' presentation at the conference?

You can watch the presentation via a webcast available on the Events & Presentations page of the Celldex website.

What is the focus of Celldex Therapeutics as mentioned in the press release?

Celldex Therapeutics focuses on developing monoclonal and bispecific antibodies to treat inflammatory diseases and various forms of cancer.

Is there a replay available for the Celldex conference presentation?

Yes, a replay of the presentation will be available for 14 days following the event.

What is the stock symbol for Celldex Therapeutics?

The stock symbol for Celldex Therapeutics is CLDX.